CME Stock Analysis: Buy, Sell, or Hold?
CME - CME Group Inc.
$252.64
2.11 (0.84%)
▲
5d:
-9.48%
30d:
-12.97%
90d:
-21.05%
HOLD
LOW Confidence
Analysis Updated: Jun 3, 2026 12:00 AM ET
Earnings: Jul 22, 2026
Smart Money Accumulation
None View Scanner →
Strength: 6.7/10
Get Alerted When CME Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CME shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: CME shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$379.73
Based on 4.6% avg growth
INTRINSIC VALUE TODAY
$235.78
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 23.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CME is currently trading at $252.64, which is considered oversold relative to its 30-day fair value range of $271.33 to $297.43. From a valuation perspective, the stock is trading at a discount (Forward PE: 19.6) compared to its historical average (23.5). Remarkably, the market is currently pricing in an annual earnings decline of 5.9% over the next few years. This pessimistic expectation contrasts with the company's recent 21.3% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, CME is showing sideways momentum. Immediate support is located at $244.56, while resistance sits at $301.90.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $306.47 (+21.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CME is showing sideways momentum. Immediate support is located at $244.56, while resistance sits at $301.90.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $306.47 (+21.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$271.33 -
$297.43
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
Protect Your Profits
Holding CME? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 21.3% below Wall St target ($306.47)
- CAUTION: Recommendation downgraded due to -9.5% 5-day decline
Trading Range Analysis
30-Day Trading Range
$271.33 -
$297.43
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$244.56
Resistance Level
$301.91
Current Trend
Sideways
Technical data as of
Jun 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
19.58
Wall Street Target
$306.47
(+21.3%)
Revenue Growth (YoY)
14.4%
Earnings Growth (YoY)
21.3%
Profit Margin
63.3%
Valuation Discount vs History
-5.9% cheaper
PE vs Historical
19.6 vs 23.5
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-5.9%
(market-implied from PE analysis)
1-Year Target
$237.73
(-6%)
2-Year Target
$223.71
(-12%)
3-Year Target
$210.51
(-17%)
3-Yr Target (if PE normalizes)
(PE: 20→24)
$252.70
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.9, Growth: 5.2%)
$329.14
(+30%)
Base:
(SPY PE: 19.6, Growth: 5.2%)
$294.09
(+16%)
Bear:
(PE: 16.6, Growth: 5.2%)
$249.97
(-1%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (24x PE), but valuation improves significantly next year (20x PE) as earnings recover.
Trailing PE: 23.81 | Current EPS (TTM): $11.72
Bull Case
$338.05
(+22%)
Analyst growth 10.1%, PE expands to 26.2
Base Case
$307.32
(+11%)
Market implied 10.1%, PE stable at 23.8
Bear Case
$189.79
(-32%)
Severe decline -20.0%, PE contracts to 20.2
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 19.6 to 23.5
Stabilization Target:
$303.27
(+20.0%)
PE Expansion Potential:
+20.0%
Share & Embed Analysis
Last updated: June 03, 2026 6:24 PM ET
Data refreshes hourly during market hours. Next update: 7:24 PM
Data refreshes hourly during market hours. Next update: 7:24 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CME showing a specific setup today?
Insider Activity (6 Months)
4
Buys
6
Sells
Net
INSIDERS SELLING
Recent Transactions
Jonathan L Marcus
SELL
3291 shares
2026-03-17
Bryan T Durkin
SELL
4200 shares
2026-02-23
Martin J Gepsman
SELL
300 shares
2026-02-20
Top Rated Financial Data & Stock Exchanges Stocks
Top-rated stocks in Financial Data & Stock Exchanges by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SPGI
S&P Global Inc |
STRONG BUY
26 analysts |
$534 | 58 HOLD |
|
COIN
Coinbase Global Inc |
HOLD
29 analysts |
$232 | 49 HOLD |
|
MCO
Moodys Corporation |
BUY
25 analysts |
$536 | 61 BUY |
|
TRU
TransUnion |
STRONG BUY
20 analysts |
$90 | 56 HOLD |
|
MSCI
MSCI Inc |
BUY
19 analysts |
$685 | 63 BUY |
Advanced CME Option Strategies
Professional options setups generated by AI based on today's CME price and gamma walls.
